Invesaro

Stocks DAKT Financial statements

Financial statements

DAKTRONICS INC /SD/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DAKTRONICS INC /SD/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue587611570609482611754818756839
Cost of revenue446465439470361494603596561610
Gross profit140146130139121117151222195229
Research and development29.135.535.637.826.8293035.738.943.5
General and administrative34.234.934.835.22832.638.742.663.559.9
Operating expenses125133135139103113130135162168
Operating income15.412.5-4.73-0.1717.14.0521.487.133.160.8
Interest expense0.230.220.160.110.30.051.133.42.871.46
Interest income0.220.211.535.836.06
Other non-operating income-0.35-0.54-1.09-0.54-2.98-3.11-7.21-13.1-17.8-6.14
Pre-tax income15.612.4-4.94-0.0114.11.1113.354.1-5.8558.3
Income tax5.256.87-3.99-0.53.130.526.4619.44.2713
Net income10.35.56-0.960.4910.90.596.834.6-10.145.4
EBITDA3430.213.917.634.219.438.410652.780.2
EPS, basic0.230.13-0.020.010.240.010.150.75-0.210.93
EPS, diluted0.230.12-0.020.010.240.010.150.74-0.210.92
Shares, basic (weighted)44.144.544.9454545.245.445.947.648.6
Shares, diluted (weighted)44.344.944.945.345.245.345.546.547.649.4
Dividend per share0.310.280.280.20

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents32.629.735.440.477.617.12481.3128132
Short-term investments1.2304.020.530
Receivables78.877.465.572.667.810111011792.8119
Inventory66.575.378.886.874.4134149138106110
Other current assets7.559.038.329.637.45159.688.538.5211.3
Total current assets258264254252265318343402381448
Property, plant and equipment66.768.165.367.558.766.872.171.873.964.3
Goodwill7.818.267.897.748.417.933.243.233.193.69
Intangible assets4.713.684.913.352.081.471.140.840.573.26
Total assets355359349373375441468528503554
Accounts payable51.548.844.947.840.376.367.560.846.768.6
Accrued liabilities2528.532.136.630.735364341.744.9
Deferred revenue12.139.447.250.964.590.491.565.569.165.3
Short-term debt01.51.51.15
Total current liabilities131131134146147214210192172194
Long-term debt17.853.210.59.63
Other non-current liabilities2.852.291.3422.17.827.085.715.766.845.29
Total liabilities157161162196182249267289231254
Total debt17.854.71210.8
Paid-in capital3840.342.644.646.648.450.3118190197
Retained earnings11410793.685.19696.6103138128173
Treasury stock-1.83-1.83-1.83-7.47-7.3-10.3-10.3-10.3-39.8-65.3
Other comprehensive income-4.38-2.71-4.36-5.28-2.34-4.93-5.53-6.53-6.16-4.05
Shareholders' equity198198188177194192201239272301
Total equity198198188177194192201239272301
Total liabilities and equity355359349373375441468528503554

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income10.35.56-0.960.4910.90.596.834.6-10.145.4
Depreciation and amortization18.617.818.617.717.115.41719.319.519.3
Stock-based compensation2.912.642.482.272.071.972.032.092.944.91
Deferred income tax-2.043.15-3.38-2.181.31-1.56-3.63-9.07-6.39.94
Change in receivables-2.722.2710.9-7.464.86-33.9-10.4-7.7325.2-26
Change in inventory3.58-8.52-4.08-8.3513.9-61.2-15.110.932.5-3.42
Change in payables5.54-2.57-2.752.38-7.0833-5.34-7.12-14.128.7
Cash from operations39.430.429.510.866.2-271563.297.749.2
Capital expenditures-8.5-18.1-17.3-18.1-7.89-20.4-25.4-17-19.5-14.9
Acquisitions00-2.2500
Purchases of investments-24.2-17.4-25.300-4.0500
Sales and maturities of investments15.915.333.725.21.2303.490.5500
Cash from investing-18.2-19.6-11.8-4.27-10.2-31.4-25.4-21.3-23.8-19.6
Debt issued001.2300
Debt repaid-0.92-1.05-0.45-2.15-0.46-0.2-0.31-0.41-0.41-0.1
Stock issued0.340.521.32000.010.021.35.151.8
Share buybacks-1.8300-5.640-3.1800-29.5-25.6
Dividends paid-13.7-12.4-12.6-8.9900
Cash from financing-16.3-13.3-11.9-1.98-15.6-3.5817.615.1-27.4-26.2
Exchange rate effect-0.59-0.620.220.11-0.42-0.4-0.52-0.07-0.650.79
Net change in cash4.31-3.085.994.6740-62.46.685745.84.13
Free cash flow30.912.212.3-7.2858.3-47.4-10.446.378.234.3
Interest paid0.230.190.180.050.260.021.082.863.070.85
Income taxes paid3.28.94-1.930.982.561.957.4926.517.85.12

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $17.02 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin27.6%Gross profit / revenue.
Operating margin7.3%Operating income / revenue.
EBITDA margin9.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin7.2%Pre-tax income / revenue.
Net margin5.7%Net income / revenue.
FCF margin4.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin6.4%Cash from operations / revenue.
Effective tax rate21.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)15.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)8.0%Net income / average total assets.
Return on invested capital (ROIC)28.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue5.3%Research and development expense / revenue.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.7%Capital expenditures / revenue.
D&A / revenue2.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y10.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y17.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y13.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y83.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y41.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y28.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y52.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y27.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y18.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y88.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y32.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y83.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y30.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-49.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y48.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-5.8%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-56.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-10.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y10.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y14.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y9.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y10.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y8.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.17xCurrent assets / current liabilities.
Quick ratio1.34x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.67x(Cash + short-term investments) / current liabilities.
Debt / equity0.03xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets1.7%Total debt / total assets.
Liabilities / assets47.7%Total liabilities / total assets.
Net debt-$144.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-1.76xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$270.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets1.1%(Goodwill + intangible assets) / total assets.
Tangible book value$310.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.41xRevenue / average total assets.
Fixed asset turnover13.3xRevenue / average property, plant and equipment.
Inventory turnover5.27xCost of revenue / average inventory.
Days inventory69 days365 x average inventory / cost of revenue.
Receivables turnover5.52xRevenue / average receivables.
Days sales outstanding66 days365 x average receivables / revenue.
Days payables47 days365 x average accounts payable / cost of revenue.
Cash conversion cycle88 daysDays inventory + days sales outstanding - days payables.
FCF conversion82.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow27.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.99Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$17.47Revenue / diluted weighted shares.
FCF per share$0.81Free cash flow / diluted weighted shares.
Operating cash flow per share$1.12Cash from operations / diluted weighted shares.
Book value per share$6.50Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.36Tangible book value / shares outstanding.
Cash per share$3.16(Cash + short-term investments) / shares outstanding.
Buybacks / FCF48.6%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$822.2MShare price x shares outstanding.
Enterprise value$678.1MMarket cap + total debt - cash - short-term investments.
P/E17.0xMarket cap / net income. Only when net income is positive.
P/S0.96xMarket cap / revenue.
P/B2.59xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.65xMarket cap / tangible book value, when positive.
P/FCF20.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.1xMarket cap / cash from operations, when positive.
EV/Sales0.79xEnterprise value / revenue.
EV/EBIT10.8xEnterprise value / operating income, when both are positive.
EV/EBITDA8.30xEnterprise value / EBITDA, when both are positive.
EV/FCF17.0xEnterprise value / free cash flow, when both are positive.
FCF yield4.8%Free cash flow / market cap.
Earnings yield5.9%Net income / market cap (the inverse of P/E).
Shareholder yield2.4%(Dividends paid + share buybacks) / market cap.
PEG0.20xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was DAKTRONICS INC /SD/'s revenue in fiscal 2026?

DAKTRONICS INC /SD/ reported revenue of $838.7M for fiscal 2026, 10.9% higher than the year before.

Was DAKTRONICS INC /SD/ profitable in fiscal 2026?

Yes. Net income was $45.4M, a net margin of 5.4%.

How much free cash flow did DAKTRONICS INC /SD/ generate in fiscal 2026?

Cash from operations of $49.2M minus capital expenditures of $14.9M left free cash flow of $34.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DAKTRONICS INC /SD/